|
TARS2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.201430E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.731800E-02 |
| Normal-vs-Stage2 |
9.051600E-01 |
| Normal-vs-Stage3 |
1.940760E-01 |
| Normal-vs-Stage4 |
6.709200E-01 |
| Stage1-vs-Stage2 |
4.016600E-01 |
| Stage1-vs-Stage3 |
9.997400E-01 |
| Stage1-vs-Stage4 |
4.290600E-01 |
| Stage2-vs-Stage3 |
4.425000E-01 |
| Stage2-vs-Stage4 |
8.443000E-01 |
| Stage3-vs-Stage4 |
5.099400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.169500E-02 |
| Normal-vs-AfricanAmerican |
5.680200E-01 |
| Normal-vs-Asian |
1.794040E-01 |
| Caucasian-vs-AfricanAmerican |
6.441400E-01 |
| Caucasian-vs-Asian |
2.039200E-01 |
| AfricanAmerican-vs-Asian |
2.395200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.616400E-02 |
| Normal-vs-Female |
6.018000E-01 |
| Male-vs-Female |
1.868040E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.881400E-01 |
| Normal-vs-Age(41-60Yrs) |
2.914200E-01 |
| Normal-vs-Age(61-80Yrs) |
1.363180E-01 |
| Normal-vs-Age(81-100Yrs) |
4.869400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.911800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.412200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.924400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.373600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.788400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.364000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.649000E-01 |
| Normal-vs-Grade 2 |
2.748000E-02 |
| Normal-vs-Grade 3 |
8.001200E-01 |
| Normal-vs-Grade 4 |
1.712410E-01 |
| Grade 1-vs-Grade 2 |
4.032200E-01 |
| Grade 1-vs-Grade 3 |
7.655200E-01 |
| Grade 1-vs-Grade 4 |
5.489400E-01 |
| Grade 2-vs-Grade 3 |
5.421800E-02 |
| Grade 2-vs-Grade 4 |
8.594800E-01 |
| Grade 3-vs-Grade 4 |
2.455800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.162800E-01 |
| Normal-vs-ccB subtype |
3.954000E-02 |
| ccA subtype-vs-ccB subtype |
9.310000E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.777590E-01 |
| Normal-vs-N1 |
4.173700E-02 |
| N0-vs-N1 |
2.031700E-02 |
|
|
